Validity and reliability of the chronic respiratory disease questionnaire in elderly individuals with mild to moderate non-cystic fibrosis bronchiectasis

Respiration

Volumn 90, Issue 2, 2015, Pages 89-96

  Vodanovich, Domagoj A ^a   Bicknell, Thomas J ^a   Holland, Anne E ^b,c,d   Hill, Catherine J ^c,e   Cecins, Nola ^f,g,h   Jenkins, Sue ^f,g,h   Mcdonald, Christine F ^c,e   Burge, Angela T ^b   Thompson, Philip ^f,h   Stirling, Robert G ^b   Lee, Annemarie L ^b,c,i  

^a WESTERN HEALTH   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c INSTITUTE FOR BREATHING AND SLEEP   (Australia)

^d LA TROBE UNIVERSITY   (Australia)

^e AUSTIN HEALTH   (Australia)

^f SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^g Lung Institute of Western Australia   (Australia)

^h CURTIN UNIVERSITY   (Australia)

ⁱ THE UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Bronchiectasis; Quality of life; Reliability; Responsiveness; Validity

Indexed keywords

ADULT; AGED; ARTICLE; ASSESSMENT OF HUMANS; BRONCHIECTASIS; CHRONIC RESPIRATORY QUESTIONNAIRE; CONTROLLED STUDY; CONVERGENT VALIDITY; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; CROSS-SECTIONAL STUDY; DISCRIMINANT VALIDITY; DYSPNEA; EFFECT SIZE; EXERCISE; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERNAL CONSISTENCY; LEICESTER COUGH QUESTIONNAIRE; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; NON CYSTIC FIBROSIS BRONCHIECTASIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; ST. GEORGE RESPIRATORY QUESTIONNAIRE; TEST RETEST RELIABILITY; COMPLICATION; COUGH; EXERCISE TOLERANCE; HEALTH DISPARITY; KINESIOTHERAPY; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; PULMONARY FIBROSIS; QUESTIONNAIRE; REPRODUCIBILITY; RESPIRATORY INSUFFICIENCY; SEVERITY OF ILLNESS INDEX;

AGED; BRONCHIECTASIS; COUGH; EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MALE; MIDDLE AGED; PULMONARY FIBROSIS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES;

EID: 84942191163     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000430992     Document Type: Article

References (56)

1. Barker A. Bronchiectasis. N Engl J Med. 2002; 346: 1383-1393.
2. Wilson C, Jones P, OLeary C, Cole P, Wilson R. Validation of the St Georges Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med. 1997; 156: 536-541.
3. Martinez-Garcia M, Perpina-Tordera M, Soler-Cataluna J, Roman-Sanchez P, Lloris-Bayo A, Gonzalex-Molina A. Dissociation of lung function, dyspnea ratings and pulmonary extension in bronchiectasis. Respir Med. 2007; 101: 2248-2253.
4. Martinez-Garcia M, Soler-Cataluna J, Perpina-Tordera M, Roman-Sanchez P, Soriano S. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest. 2007; 132: 1565-1572.
5. Koulouris N, Retsou S, Kosmas E, Dimakou K, Malagari K, Mantzikopoulos G, Koutsoukou A, Milic-Emili J, Jordanoglou, J. Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis. Eur Respir J. 2003; 21: 743-748.
6. King P, Holdsworth S, Vallanueva E, Vallanueva E, Gallagher M, Holmes P. Outcome in adult bronchiectasis. COPD. 2005; 2: 27-34.
7. Hester L, MacFarlane J, Tedd H, Jary H, Mc-Alinden P, Rostron L, Small T, Newton JL, De Soyza A. Fatigue in bronchiectasis. Oxford Med J. 2012; 105: 235-240.
8. Gale N, Bolton C, Duckers J, Enright S, Cockcroft J, Shale D. Systemic comorbidities in bronchiectasis. Chron Respir Dis 2012, 9: 231-238.
9. Seitz A, Olivier K, Steiner C, Montes de Oca R, Holland S, Prevots R. Trends and burden of bronchiectasis - Associated hospitalisations in the United States, 1993-2006. Chest. 2012; 138: 944-949.
10. Weycker D, Edelsberg J, Oster G, Tino G. Prevalence and economic burden of bronchiectasis. Clin Pulmon Med. 2005; 12: 205-209.
11. Martinez-Garcia M, Perpina-Tordera M, Roman-Sanchez P, Soler-Cataluna J. Quality of life determinants in patients with clinically stable bronchiectasis. Chest. 2005; 128: 739-745.
12. King P, Holdsworth S, Freezer N, Villanueva E, Holmes P. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med. 2006; 100: 2183-2189.
13. Olveira C, Olveira G, Gaspar I, Dorado A, Cruz I, Soriguer F, Quittner AL, Espildora F. Depression and anxiety symptoms in bronchiectasis: associations with health-related quality of life. Qual Life Res. 2013; 22: 597-605.
14. Quittner AL, Marciel KK, Salathe MA, ODonnell AE, Gotfried MH, Ilowite JS, Metersky, ML, Flume PA, Lewis SA, McKevitt M, Montgomery BA, OFiordan TG. Preliminary quality of life questionnaire-bronchiectasis: a patient-reported outcome measure for bronchiectasis. Chest. 2014; 146: 437-448.
15. Quittner AL, ODonnell AE, Salathe MA, Lewis SA, Li X, Montgomery AB, ORiordan TG, Barker AF. Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores. Thorax. 2015; 70: 12-20.
16. Guyatt G, Berman L, Townsend M, Pugsley S, Chambers L: A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987; 42: 773-778.
17. Wijkstra P, Tenvergert E, VanAltena R, Otten V, Postma D, Krann J, Koeter GH. Reliability and validity of the Chronic Respiratory Questionnaire (CRQ). Thorax. 1994; 49: 465-467.
18. Lacasse Y, Wong E, Guyatt G: A systematic overview of the measurement properties of the Chronic Respiratory Questionnaire. Can Respir J. 1997; 4: 131-139.
19. Harper R, Brazier J, Waterhouse J, Walters S, Jones N, Howard P. Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. Thorax. 1997; 52: 879-887.
20. Chang J, Curtis J, Patrick D, Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease. Chest. 1999; 116: 1175-1182.
21. Murray M, Turnbull K, MacQuarrie S, Pentland J, Hill A. Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis. Eur Respir J. 2009; 34: 125-131.
22. Ong H, Lee A, Hill C, Holland A, Denehy L. Effects of pulmonary rehabilitation in bronchiectasis: a retrospective study. Chron Respir Dis. 2011; 8: 21-30.
23. Lee A, Hill C, Cecins N, Jenkins S, McDonald CF, Burge AT, Rautela L, Stirling RG, Thompson PJ, Holland AE. The short and long term effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: a randomised controlled trial. Respir Res. 2014; 15: 44.
24. Spruit MA, Singh SJ, Garvey C, et al; ATS/ERS Task Force on Pulmonary Rehabilitation: An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013; 188: e13-e64.
25. Nici L, Donner C, Wouters E, ZuWallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais F, Morgan M, ODonnell D, Prefault C, Reardon J, Rochester C, Schols A, Singh S, Troosters T; ATS/ERS Pulmonary Rehabilitation Writing Committee. The American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006; 173: 1390-1413.
26. Johnston C, Maxwell L, Alison J. Pulmonary rehabilitation in Australia: a national survey. Physiotherapy. 2011; 97: 284-290.
27. ONeill B, Elborn J, MacMahon J, Bradley J. Pulmonary rehabilitation and follow-on services: a Northern Ireland survey. Chron Respir Dis. 2008; 5: 149-154.
28. Brooks D, Sottana R, Bell B, Hanna M, Laframboise L, Selvanavagarajah S, Goldstein RS. Characterization of pulmonary rehabilitation programs in Canada in 2005. Can Respir J. 2007; 14: 87-92.
29. Bhalla M, Turcios N, Aponte V, Jenkins M, Leitman B, McCauley D, Naidich DP. Cystic fibrosis: scoring system with thin-section CT. Radiology. 1999; 179: 783-788.
30. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD. www.goldcopd.org. 2013 (accessed May 27, 2013
31. Bousquet J, Clark T, Hurd S. GINA guidelines for asthma and beyond. Allergy. 2007; 62: 102-112.
32. Miller M, Hankinson J, Brusasco V, et al; ATS/ERS Task Force: Standardisation of spirometry. Eur Respir J. 2005; 26: 319-338.
33. Mahler D, Wells C. Evaluation of clinical methods for rating dyspnea. Chest. 1988; 93: 580-586.
34. Williams J, Singh S, Sewell L, Guyatt G, Morgan M. Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR). Thorax. 2001; 56: 954-959.
35. Jones P, Quirk F, Baveystock C, Littlejohns P: A self-complete measure of health status for chronic airflow limitation. The St Georges Respiratory Questionnaire. Am Rev Respir Dis. 1992; 145: 1321-1327.
36. Birring S, Prudon B, Carr A, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003; 58: 339-343.
37. Zigmond A, Snaith R. The hospital anxiety and depression scale. Acta Pyschiatrica Scand. 1983; 67: 361-370.
38. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories: ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166: 111-117.
39. Portney LG, Watkins MP. Foundations of Clinical Research. Applications to Practice, ed 3. Pearson Prentice Hall, Upper Saddle River, 2009.
40. Tsai C, Hodder R, Page J, Cydulka R, Rowe B, Camargo C Jr. The short-Term chronic respiratory disease questionnaire was a valid, reliable and responsive quality-of-life instrument in acute exacerbations of chronic obstructive pulmonary disease. J Clin Epidemiol. 2008; 61: 489-497.
41. Schunemann HJ, Griffith L, Jaeschke R, Goldstein R, Stubbing D, Austin P, Guyatt GH: A comparison of the original chronic respiratory questionnaire with a standardised version. Chest. 2003; 124: 1421-1429.
42. Schunemann HJ, Goldstein R, Mador MJ, McKim D, Stahl E, Puhan M, Griffith LE, Grant B, Austin P, Collins R, Guyatt GH: A randomised trial to evaluate the self-Administered standardised chronic respiratory questionnaire. Eur Respir J. 2005; 25: 31-40.
43. Jaeschke R, Singer J, Guyatt G. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trial. 1989; 10: 407-415.
44. Jones P. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J. 2002; 19: 398-404.
45. Ozalp O, Inal-Ince D, Calik E, Vardar-Yagli N, Saglam M, Savci S, Arikan H, Bosnak-Guclu M, Coplu L. Extrapulmonary features of bronchiectasis: muscle function, exercise capacity, fatigue and health status. Multidiscip Respir Med. 2012; 7: 3.
46. Alves de Camargo A, Amaral T, Rached S, Athanazio RA, Lanza FC, Sampaio LM, de Carvalho CR, Cukier A, Stelmach R, Dal Corso S. Incremental shuttle walking test: a reproducible and valid test to evaluate exercise tolerance in adults with non-cystic fibrosis bronchiectasis. Arch Phys Med Rehabil. 2013; 95: 892-899.
47. Nicotra M, Fivera M, Dale A, Shepherd R, Carter R. Clinical, pathophysiologic and microbiologic characterisation of bronchiectasis in an aging cohort. Chest. 1995; 108: 955-961.
48. OLeary C, Wilson C, Hansell D, Cole P, WIlson R, Jones P. Relationship between psychological well-being and lung health status in patients with bronchiectasis. Respir Med. 2002; 96: 686-692.
49. Moreno G, Vasconcelos F, Cisneros C, Gomez-Punter R, Segrelles C, Ancochea J. Presence of anxiety and depression in patients with bronchiectasis unrelated to cystic fibrosis. Arch Bronconeumol. 2013; 49: 415-420.
50. Lee AL, Button BM, Ellis SJ, Stirling RG, Wilson JW, Holland AE, Denehy L. Clinical determinants of the 6-minute walk test in non-CF bronchiectasis. Respir Med. 2009; 103: 780-785.46.
51. Jenkins S, Cecins N, Camarri B, Williams C, Thompson P, Eastwood P. Regression equations to predict 6-minute walk distance in middle-Aged and elderly adults. Physiother Theory Pract. 2009; 25: 516-522.
52. Zan Zellar M, Caetano P, Amorim A, Viana P, Martins P, Gaspar L, Hespanhol V, Gomes I. Pulmonary rehabilitation in patients with bronchiectasis: pulmonary function, arterial blood gases and the 6-minute walk test. J Cardiopulm Rehabil Prev. 2012; 32: 278-283.
53. Mandal P, Sidhu M, Kope L, Pollock W, Stevenson LM, Pentland JL, Turnbull K, Mac-Quarrie S, Hill AT: A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis. Respir Med. 2012; 106: 1647-1654.
54. Newall C, Stockley R, Hill S. Exercise training and inspiratory muscle training in patients with bronchiectasis. Thorax. 2005; 60: 943-948.
55. Redding GJ. Bronchiectasis in children. Pediatr Clin North Am. 2009; 56: 157-171.
56. Karadag B, Karakoc F, Ersu R, et al. Non-cystic fibrosis bronchiectasis in children: a persistent problem in developing countries. Respiration. 2005; 72: 233-238.